Trial Profile
Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of K-312 in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs K 312 (Primary)
- Indications Hyperlipidaemia
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors Kowa Research Institute
- 16 Feb 2016 New trial record